Table 3.
CdMT | Glutamine codons | ||||
---|---|---|---|---|---|
CAA | UAA | UAG | CAG | Total | |
TpigMT-1 | 3 | 1 | 0 | 0 | 4 |
TpyrMT-1 | 0 | 0 | 0 | 0 | 0 |
TpyrMT-2 | 2 | 10 | 2 | 0 | 14 |
TtheMTT1 | 2 | 4 | 1 | 0 | 7 |
TtheMTT3 | 2 | 5 | 1 | 1 | 9 |
TtheMTT5 | 2 | 1 | 0 | 0 | 3 |
TrosMTT1 | 2 | 2 | 0 | 0 | 4 |
TtroMTT1 | 3 | 1 | 0 | 0 | 4 |
TmobMT1 | 4 | 1 | 0 | 0 | 5 |
TvorMT1 | 4 | 0 | 0 | 0 | 4 |
ThegMT1 | 2 | 2 | 0 | 0 | 4 |
ThegMT2 | 2 | 4 | 2 | 0 | 8 |
ThegMT3 | 1 | 3 | 0 | 1 | 5 |
ThegMT4 | 1 | 10 | 5 | 1 | 17 |
TborMTT1 | 2 | 4 | 0 | 0 | 6 |
TborMTT2 | 3 | 3 | 1 | 0 | 7 |
TelliMTT1 | 1 | 6 | 2 | 0 | 9 |
TelliMTT2 | 3 | 5 | 3 | 0 | 11 |
TmalaMTT1 | 1 | 5 | 1 | 0 | 7 |
TmalaMTT2 | 3 | 3 | 1 | 0 | 7 |
TmalaMTT3 | 2 | 5 | 0 | 0 | 7 |
TmalaMTT4 | 0 | 5 | 0 | 0 | 5 |
TpatMTT1 | 2 | 4 | 1 | 0 | 7 |
TpatMTT2 | 2 | 4 | 5 | 0 | 11 |
TamerMTT1 | 1 | 4 | 1 | 0 | 6 |
TamerMTT2 | 2 | 4 | 1 | 0 | 7 |
Total (%) a | 52 (29.21 %) | 96 (53.93 %) | 27 (15.17 %) | 3 (1.69 %) | 178 (100 %) |
CuMT | |||||
TpigMT-2 | 6 | 0 | 0 | 0 | 6 |
TtheMTT2 | 4 | 0 | 0 | 0 | 4 |
TtheMTT4 | 4 | 0 | 0 | 0 | 4 |
TrosMTT2 | 5 | 0 | 0 | 0 | 5 |
TtroMT1 | 5 | 0 | 0 | 1 | 6 |
TtroMT2 | 2 | 0 | 1 | 1 | 4 |
Sp1.7-MT1 | 3 | 2 | 2 | 0 | 7 |
TelliMTT6 | 5 | 1 | 0 | 0 | 6 |
TelliMTT8 | 3 | 2 | 0 | 0 | 5 |
TmalaMTT5 | 3 | 1 | 0 | 0 | 4 |
TborMTT3 | 4 | 7 | 2 | 0 | 13 |
TborMTT4 | 2 | 0 | 0 | 0 | 2 |
TborMTT6 | 4 | 7 | 2 | 0 | 13 |
TborMTT7 | 5 | 2 | 1 | 0 | 8 |
TborMTT8 | 5 | 0 | 0 | 0 | 5 |
TamerMTT3 | 4 | 0 | 0 | 0 | 4 |
ImMTT2 | 1 | 9 | 0 | 0 | 10 |
Total (%) a | 65 (61.32 %) | 31 (29.24 %) | 8 (7.55 %) | 2 (1.89 %) | 106 (100 %) |
New MTs reported in this study are in bold text.a Total glutamine residues using a type of codon and percentage